课题基金 / 基金详情

Control of NF-kB and inflammation by COMMD proteins

Control of NF-kB and inflammation by COMMD proteins
COMMD 蛋白对 NF-kB 和炎症的控制
批准号:
7209237
负责人:
Ezra Burstein
金额:
$21.81万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2011-01-31

项目摘要

项目成果

Ezra Burstein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NF-kB is a transcription factor that regulates expression of factors critical to inflammation and cell survival, and thus plays a central role in multiple human diseases. NF-kB is regulated by IkB which sequesters the transcription factor in the cytoplasm. In response to a variety of stimuli, IkB is transiently degraded allowing translocation of NF-kB into the nucleus where it activates expression of a wide array of genes. Interestingly, the genes that NF-kB activates are often specific to the cell type and stimulus in question and our current knowledge of this pathway cannot fully account for these differential effects. We recently discovered a novel family of conserved factors that inhibit NF-kB, called COMMD proteins. COMMD1, the prototype of this family, acts in the nucleus where it is recruited to chromatin and promotes the release of promoter-bound NF-kB. Our most recent data indicate that COMMD1 mediates ubiquitination and proteasomal degradation of NF-kB subunits through a multimeric ubiquitin ligase known as ECS-SOCS1. Since ubiquitination of NF-kB has been previously linked to its release from promoter sites, COMMD1-mediated ubiquitination provides a mechanism for its effects on chromatin-bound NF-kB. In addition, while IkB is broadly inhibitory, individual COMMDs have effects on specific subsets of kB-responsive genes. We speculate that COMMD proteins function at specific gene targets by recruiting a ubiquitin ligase to locally inhibit NF-kB. Therefore, we hypothesize that the multi-member COMMD family plays a critical role in providing specificity to the NF-kB pathway. We believe that through their effects on NF-kB, COMMDs are likely involved in inflammation and oncogenesis. The overall goals of this project are: to determine the mechanism by which COMMD1 mediates NF-kB ubiquitination (AIM 1), to elucidate the mechanisms that control the activity of COMMD1 (AIM 2) and to investigate the differential effects of COMMD proteins on gene regulation (AIM 3). Lay Description: NF-kB is a master regulator of gene expression that is responsible for turning on genes critical in inflammation. Hence, NF-kB plays a central role in diseases that have inflammation as a common feature. We have discovered a group of factors named COMMD proteins that inhibit NF-kB. The overall goal of this proposal is to understand how COMMD proteins work since their mechanism of action might provide clues to design anti-inflammatory therapies with a broad range of potential applications
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of colonic enteroendocrine cells in metabolic control
  • 批准号:
    10673003
  • 项目类别:
  • 资助金额:
    $58.99万
  • 财政年份:
    2022
  • 负责人:
    Ezra Burstein
  • 依托单位:
NF-kB Signaling Insights from a Rare X-linked Immunodeficiency Syndrome
  • 批准号:
    8891525
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2014
  • 负责人:
    Ezra Burstein
  • 依托单位:
Control of NF-kB and inflammation by COMMD proteins
Control of NF-kappaB and Inflammation by COMMD proteins
  • 批准号:
    8827759
  • 项目类别:
  • 资助金额:
    $34.58万
  • 财政年份:
    2007
  • 负责人:
    Ezra Burstein
  • 依托单位:
国内基金
海外基金
生物纳米硒通过NF-kB调控血脑屏障改善胰性脑病的神经保护机制研究
  • 批准号:
    JCZRLH202601807
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
温阳化气汤通过IL-17A/NF-kB通路调节恶性黑色素瘤中CXCL10介导的抗肿瘤免疫浸润的机制研究
  • 批准号:
    JCZRLH202601136
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于肌骨超声评价从TLR/PI3K-AKt/NF-kB通路探讨开阖枢罐法干预类风湿关节炎患者(风寒湿痹证)的临床疗效及作用机制
基于靶向黄嘌呤氧化酶和NF-kB/MAPK/NLRP3信号通路探讨女贞子治疗高尿酸血症的活性成分及其作用机理
  • 批准号:
    JCZRLH202600464
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: